← Leaderboards
Ajay K Singh
Brigham And Women'S Hospital
$273,849
Attributed
$273,849
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $110.7K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$273,849 · 4
By mechanism
M01$273,849 · 4
Top collaborators
No co-investigators on record.
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Ron Kikinis$27,906,567
- Sushrut S. Waikar$14,689,878
- Charles A Czeisler$60,536,935
- George R Washko$16,445,968
- Norman K Hollenberg$2,802,146
Others in their field
Top investigators on “Arginine”
- Claudia R Morris · Children'S Hospital &Res Ctr At Oakland$13,907,458
- Paul R Thompson · University Of South Carolina At Columbia$13,563,580
- Michael J. Detke · Embera Neurotherapeutics, Inc.$12,591,952
- John R Guy · University Of Florida$12,441,515
- Elliot Israel · Brigham And Women'S Hospital$11,585,579
- Charles David Allis · University Of Virginia Charlottesville$11,522,091
Research focus
ArginineHomocysteineBaseUnited States National Institutes Of HealthAmino AcidsInstitutionMetabolicMetabolismPurposeResearch PersonnelResourcesSourceComputer Retrieval Of Information On Scientific Projects DatabaseEnd Stage Renal FailureFunctional DisorderFundingGrantHomocystineClinical ResearchAminoacid MetabolismHuman SubjectPathologic ProcessKidney FunctionPatient Oriented Research
Grant awards (5)
METABOLIC BASIS OF ENDOTHELIAL DYSFUNCTION IN END-STAGE RENAL DISEASE$4,104
M01 · FY2008 · RR · contact PI
METABOLIC BASIS OF ENDOTHELIAL DYSFUNCTION IN END-STAGE RENAL DISEASE$27,504
M01 · FY2007 · RR · contact PI
METABOLIC BASIS OF ENDOTHELIAL DYSFUNCTION IN END-STAGE RENAL DISEASE$45,610
M01 · FY2006 · RR · contact PI
METABOLIC BASIS OF ENDOTHELIAL DYSFUNCTION IN END-STAGE RENAL DISEASE$110,746
M01 · FY2005 · RR
Metabolic Basis of Endothelial Dysfunction in End-Stage Renal Disease$85,885
M01 · FY2004 · RR